COLL

COLLEGIUM PHARMACEUTICAL INC

18.5700
USD
-0.0538%
18.5700
USD
-0.0538%
13.7000 29.9000
52 weeks
52 weeks

Mkt Cap 617.41M

Shares Out 33.25M

new Chat
Send me real-time posts from this site at my email

Today is FDA action date for Collegium's Xtampza ER approval

Today is the FDA's PDUFA date for approving Collegium Pharmaceutical's (COLL -2%) NDA for lead product candidate Xtampza ER (oxycodone extended-release capsules), an abuse-deterrent oral formulation of the widely...


More
Followers
3